Product Name :
Delapril hydrochloride
Description:
Delapril hydrochloride is an angiotensin-converting enzyme (ACE) inhibitor for the treatment of cardiovascular diseases.
CAS:
83435-67-0
Molecular Weight:
489.00
Formula:
C26H33ClN2O5
Chemical Name:
2-[(2S)-N-(2,3-dihydro-1H-inden-2-yl)-2-{[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino}propanamido]acetic acid hydrochloride
Smiles :
Cl.C[C@H](N[C@@H](CCC1C=CC=CC=1)C(=O)OCC)C(=O)N(CC(O)=O)C1CC2C=CC=CC=2C1
InChiKey:
FDJCVHVKXFIEPJ-JCNFZFLDSA-N
InChi :
InChI=1S/C26H32N2O5.ClH/c1-3-33-26(32)23(14-13-19-9-5-4-6-10-19)27-18(2)25(31)28(17-24(29)30)22-15-20-11-7-8-12-21(20)16-22;/h4-12,18,22-23,27H,3,13-17H2,1-2H3,(H,29,30);1H/t18-,23-;/m0./s1
Purity:
≥98% (or refer to the Certificate of Analysis)
Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis
Storage Condition :
Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.
Shelf Life:
≥12 months if stored properly.
Stock Solution Storage:
0 – 4 oC for 1 month or refer to the Certificate of Analysis.
Additional information:
Delapril hydrochloride is an angiotensin-converting enzyme (ACE) inhibitor for the treatment of cardiovascular diseases.|Product information|CAS Number: 83435-67-0|Molecular Weight: 489.00|Formula: C26H33ClN2O5|Chemical Name: 2-[(2S)-N-(2,3-dihydro-1H-inden-2-yl)-2-{[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino}propanamido]acetic acid hydrochloride|Smiles: Cl.C[C@H](N[C@@H](CCC1C=CC=CC=1)C(=O)OCC)C(=O)N(CC(O)=O)C1CC2C=CC=CC=2C1|InChiKey: FDJCVHVKXFIEPJ-JCNFZFLDSA-N|InChi: InChI=1S/C26H32N2O5.{{Ocrelizumab} web|{Ocrelizumab} Immunology/Inflammation|{Ocrelizumab} Technical Information|{Ocrelizumab} In Vivo|{Ocrelizumab} custom synthesis|{Ocrelizumab} Autophagy} ClH/c1-3-33-26(32)23(14-13-19-9-5-4-6-10-19)27-18(2)25(31)28(17-24(29)30)22-15-20-11-7-8-12-21(20)16-22;/h4-12,18,22-23,27H,3,13-17H2,1-2H3,(H,29,30);1H/t18-,23-;/m0.{{Girentuximab} web|{Girentuximab} Metabolic Enzyme/Protease|{Girentuximab} Biological Activity|{Girentuximab} In Vivo|{Girentuximab} supplier|{Girentuximab} Epigenetic Reader Domain} /s1|Technical Data|Appearance: Solid Power|Purity: ≥98% (or refer to the Certificate of Analysis)|Solubility: DMSO : 250 mg/mL (511.PMID:35126464 25 mM; Need ultrasonic). H2O : 1.72 mg/mL (3.52 mM; ultrasonic and warming and heat to 60°C).|Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis|Storage Condition: Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.|Shelf Life: ≥12 months if stored properly.|Stock Solution Storage: 0 – 4 oC for 1 month or refer to the Certificate of Analysis.|Drug Formulation: To be determined|HS Tariff Code: 382200|How to use|In Vivo:|Delapril (3 mg/kg; administered orally for 2 weeks) exerts potent ACE inhibitory activity in spontaneously hypertensive rat (SHR) . Delapril (1-10 mg/kg; orally) exerts a marked and long-lasting antihypertensive action in various experimental models of hypertension.|Products are for research use only. Not for human use.|